W.G. 56· Male
Your study
Likely eligible
Patient snapshotDe-identified — from your records
Biopsy-confirmed MASH (NASH), fibrosis stage F2, type 2 diabetes, BMI 33.
SourceHepatology referral
Age / sex56 · Male
AI pre-screen
Likely eligible
89/100
Meets criteria
Biopsy-confirmed steatohepatitis at F2
T2D and BMI meet inclusion
Fibrosis stage inside F2-F3 window
To confirm at screening
Recent alcohol history
Hep B/C serology on file?
Rare clean fit for a MASH trial — staging already confirmed on biopsy.
AI-assisted decision support. A qualified team member must review and decide.
Matched study
Clinical Trial on Agitation in Alzheimer's Dementia
Added to your study
This candidate is in your applicant pipeline.